Prostate Cancer – 20-Year Comparative Mortality and Survival Analysis by Age, Race/Ethnicity, Stage, Grade, Disease Duration and Cohort Entry Period: A Systematic Review of 648,114 cases for Diagnosis Years 1975-2022

Prostate cancer is a major cause of disease and mortality among older men (mean age 67.3 years old) in the United States and globally. Given the biological heterogeneity of this cancer in this short- and long-term United States retrospective population-based analysis, the focus is on incidence, mortality, and survival by age, race/ethnicity, stage, and severity in cohort entry time periods (1975-99 and 2000-22), and disease duration. This comparative cohort short- and long-term study is intended to provide age-adjusted epidemiologic and demographic survival and mortality data for convenient reference by all physicians, scientists, insurance underwriters, and others interested in cancer mortality follow-up.

Authors

Publication Details

Journal
Journal of Insurance Medicine
Published
2026-06-16
DOI
https://doi.org/10.17849/insm-53-2-1-34.1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prostate Cancer – 20-Year Comparative Mortality and Survival Analysis by Age, Race/Ethnicity, Stage, Grade, Disease Duration and Cohort Entry Period: A Systematic Review of 648,114 cases for Diagnosis Years 1975-2022

Anthony F. Milano
Journal of Insurance Medicine
Prostate Cancer Diagnosis and Treatment
article

Prostate Cancer – 20-Year Comparative Mortality and Survival Analysis by Age, Race/Ethnicity, Stage, Grade, Disease Duration and Cohort Entry Period: A Systematic Review of 648,114 cases for Diagnosis Years 1975-2022

Anthony F. Milano
article en

Abstract

Prostate cancer is a major cause of disease and mortality among older men (mean age 67.3 years old) in the United States and globally. Given the biological heterogeneity of this cancer in this short- and long-term United States retrospective population-based analysis, the focus is on incidence, mortality, and survival by age, race/ethnicity, stage, and severity in cohort entry time periods (1975-99 and 2000-22), and disease duration. This comparative cohort short- and long-term study is intended to provide age-adjusted epidemiologic and demographic survival and mortality data for convenient reference by all physicians, scientists, insurance underwriters, and others interested in cancer mortality follow-up.

Journal of Insurance MedicineVol. 53(2)
Good health and well-being
Openalex Percentile: Top 8%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prostate Cancer – 20-Year Comparative Mortality and Survival Analysis by Age, Race/Ethnicity, Stage, Grade, Disease Duration and Cohort Entry Period: A Systematic Review of 648,114 cases for Diagnosis Years 1975-2022 — Anthony F. Milano · Journal of Insurance Medicine (2026) | TGRS Research Map | TGRS